Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)

NCT00326625 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

366

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: 40 mg glatiramer acetate
DRUG: Placebo

Sponsor

Teva Pharmaceutical Industries, Ltd.